- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Optimal control of blood sugar, BP, and AF reduces risk of heart failure: Study
China: Conservative blood sugar control, and rhythm control of atrial fibrillation (AF), in addition to intensive BP control, are crucial for delaying the progression of heart failure in type 2 diabetes, hypertension, and AF patients, according to a recent study. The study is published in the Internal Medicine Journal.
Atrial fibrillation, hypertension and type 2 diabetes mellitus (T2DM) are risk factors for heart failure with preserved ejection fraction (HFpEF). This study by Li Fan, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China, and colleagues examined the effects of the simultaneous control of all 3 conditions on the new‐onset HFpEF in this population.
The study involved 552 patients with T2DM, hypertension and AF sans clinical signs or symptoms of heart failure. They were followed for 5 years to examine the effects of blood sugar control (hemoglobin A1c: < 7.0%, 7.0%‐8.0% and > 8.0%), blood pressure (BP) control (systolic BP: <120 mmHg, 120‐140 mmHg and >140 mmHg) or rhythm versus rate control for AF on new‐onset HFpEF.
Key findings of the study include:
- With a follow‐up of 5 years, the new‐onset HFpEF occurred in 62 of 552 enrolled participants.
- Among the different control level for diabetes, hypertension and AF, the intensive blood glucose (BG) control, poor BP control and rate control of AF had the highest risk of new‐onset HFpEF, and the conservative BG control, intensive BP control and rhythm control of AF had the lowest risk of new‐onset HFpEF.
- Multivariable cox regression analysis showed that both poor BP control (HR: 1.421) and rate control of AF (HR: 1.362) were independently associated with the development of new‐onset HFpEF.
Our findings demonstrate that besides intensive BP control, rhythm control of AF and conservative blood sugar control are crucial factors for delaying the progression of HFpEF among patients with AF, T2DM, and hypertension.
The study, "Optimal management of blood glucose, blood pressure and atrial fibrillation to reduce the risk of heart failure with preserved ejection fraction," is published in the journal Internal Medicine Journal.
DOI: https://doi.org/10.1111/imj.15006
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751